Results 191 to 200 of about 34,959 (356)

The Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs From the Direct-acting Antiviral (DAA) Era: A Population-Based Study

, 2021
Sofia Bartlett, Stanley Wong, Amanda Yu, Margo Pearce, Julia L. MacIsaac, Susan Nouch, Prince Adu, James Wilton, Hasina Samji, Emilia Clementi, Hector Velásquez, Dahn Jeong, Mawuena Binka, Maria Alvarez, Jason Wong, Jane A. Buxton, Mel Krajden, Naveed Z. Janjua   +17 more
openalex   +2 more sources

Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19

Journal of Clinical and Experimental Hepatology, 2021
Kumar, Pramod, Kulkarni, Anand, Sharma, Mithun, Rao, Padaki N.   +3 more
openaire   +3 more sources

Chronic Hepatitis C in the Direct-Acting Antivirals Era: Carcinogenesis and Clinical Implications. [PDF]

Diseases
Aydin Y, Kurt R, Tahan V, Daglilar E.
europepmc   +1 more source

Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals

Fried, Michael W., NANCY R. REAU, Carol E. Golin, D. M. Evon, Reeve, Bryce B., Anna S. Lok, Joseph K. Lim, Adrian M. Di Bisceglie, David R. Nelson, Jipcy Amador, Marina Serper, Souvik Sarkar, Paul W. Stewart, Richard K. Sterling, K. Jayasankara Reddy   +14 more
openalex   +1 more source

Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study [PDF]

, 2019
Qiushi Chen, Turgay Ayer, Emily D. Bethea, Fasiha Kanwal, Xiaojie Wang, Mark S. Roberts, Yueran Zhuo, Stefano Fagiuoli, Jörg Petersen, Jagpreet Chhatwal   +9 more
openalex   +1 more source

The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals

, 2021
Lisa Townshend‐Bulson, Elena Roik, Youssef Barbour, Dana Bruden, Chriss Homan, Hannah Espera, Timothy J. Stevenson, Annette Hewitt, Wileina Rhodes, James Gove, Julia Plotnik, Mary Snowball, John McGilvray, Brenna C. Simons, Janet M. Johnston, Brian J. McMahon   +15 more
openalex   +2 more sources

Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus [PDF]

, 2016
Fasiha Kanwal, Jennifer R. Kramer, Hashem B. El‐Serag, Susan M. Frayne, Jack A. Clark, Yumei Cao, Thomas J. Taylor, Donna L. Smith, Donna L. White, Steven M. Asch   +9 more
openalex   +1 more source

Ribozymes for RNA‐Catalyzed RNA Methylation and Labeling

Angewandte Chemie International Edition, EarlyView.
Ribozymes are powerful tools for site‐specific RNA modification. Their activities range from installing tags and fluorophores to generating natural RNA methylations, making them valuable tools to uncover the many functions that RNA plays in nature.
Carolin P. M. Scheitl, Claudia Höbartner   +1 more
wiley   +1 more source

Hepatitis C treatment in a jail setting: A retrospective cohort analysis of low-barrier initiation of direct acting antivirals. [PDF]

Int J Drug Policy
Berk J, Akiyama MJ, Schachman N, Junkin R, Bhowmik A, Davis D, Williams S, Rich J, Murphy M.   +8 more
europepmc   +1 more source

Occurrence and Recurrence of Hepatocellular Carcinoma After Successful Direct-Acting Antiviral Therapy for Patients With Chronic Hepatitis C Virus Infection.

, 2017
Sirisha Grandhe, Catherine Frenette
openalex